Valuation: Amneal Pharmaceuticals, Inc.

Market Cap 7.02B 6.12B 5.77B 5.25B 9.85B 673B 9.86B 69.06B 26.62B 343B 26.38B 25.79B 1,106B P/E 2026 *
41.1x
P/E 2027 * 25.1x
Enterprise Value 9.34B 8.14B 7.67B 6.98B 13.1B 895B 13.11B 91.85B 35.4B 456B 35.08B 34.3B 1,471B EV / Sales 2026 *
2.96x
EV / Sales 2027 * 2.62x
Free-Float
44.36%
Yield 2026 *
-
Yield 2027 * -
1 day+7.75%
1 week+17.07%
Current month+15.40%
1 month+12.56%
3 months+24.37%
6 months+70.41%
Current year+60.00%
1 week 16.56
Extreme 16.56
21.18
1 month 16.56
Extreme 16.56
21.18
Current year 11.71
Extreme 11.71
21.18
1 year 9.49
Extreme 9.49
21.18
3 years 3.36
Extreme 3.36
21.18
5 years 1.24
Extreme 1.24
21.18
10 years 1.24
Extreme 1.24
24.48
Manager TitleAgeSince
Chief Executive Officer 59 01/08/2019
Chief Executive Officer 54 01/08/2019
Director of Finance/CFO 58 07/11/2023
Director TitleAgeSince
Director/Board Member 59 07/11/2023
Director/Board Member 70 07/11/2023
Director/Board Member 52 07/11/2023
Date Insider Type Main position Quantity % Market Cap. Importance
11/09/26 Exercice

Director

40,890 0.0128%
01/09/26 Don

Executive/Senior Manager

-80,000 0.0251%
21/08/26 Don

Executive/Senior Manager

-152,426 0.0477%
Change 5-day change 1-year change 3-year change Capi.($)
+7.75%+17.07%+105.50%+372.13% 7.02B
+1.04%+2.34%+54.91%+111.75% 1,038B
-0.19%+1.18%+52.94%+66.69% 649B
+0.20%+1.04%+18.88%+72.38% 467B
-0.77%+0.39%+33.53%+45.15% 355B
+0.06%+1.97%+18.09%+26.26% 269B
+0.22%+3.80%+9.36%+13.85% 260B
+1.95%+3.06%+37.75%+45.93% 213B
-0.12%-6.13%-32.41%-59.62% 176B
+0.30%+2.83%+31.97%+100.03% 187B
Average +0.86%+2.65%+33.05%+79.45% 362.21B
Weighted average by Cap. -0.16%+1.50%+35.46%+66.37%

Financials

2026 *2027 *
Net sales 3.15B 2.75B 2.59B 2.36B 4.42B 302B 4.43B 31.02B 11.96B 154B 11.85B 11.59B 497B 3.44B 3B 2.82B 2.57B 4.82B 329B 4.83B 33.82B 13.03B 168B 12.92B 12.63B 542B
Net income 165M 144M 136M 124M 232M 15.85B 232M 1.63B 627M 8.07B 621M 608M 26.05B 274M 239M 225M 205M 384M 26.27B 385M 2.7B 1.04B 13.38B 1.03B 1.01B 43.18B
Net Debt 2.32B 2.02B 1.9B 1.73B 3.25B 222B 3.25B 22.79B 8.79B 113B 8.71B 8.51B 365B 2B 1.74B 1.64B 1.49B 2.8B 191B 2.8B 19.62B 7.56B 97.37B 7.49B 7.33B 314B
Logo Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Employees
8,700
Date Price Change Volume
21/09/26 $20.16 +7.75% 5,908,094
18/09/26 $18.71 +2.35% 6,619,091
17/09/26 $18.28 +1.11% 2,816,756
16/09/26 $18.08 +8.59% 5,124,041
15/09/26 $16.65 -3.31% 1,793,471
Trader
Investor
Global
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
20.16USD
Average target price
22.00USD
Spread / Average Target
+9.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!